MUNICH, Germany – Aigora has signed a data partnership agreement with one of the world’s top five pharmaceutical companies, further expanding its footprint in the life sciences sector. The agreement covers the provision of longitudinal multimodal data and biospecimens across indications.
Together, they will support a broad range of research and development activities, including AI development and validation, biomarker discovery, translational research and real-world evidence generation.
Precision medicine research increasingly depends on data that follows patients over time and links imaging, pathology, clinical and molecular information with matching biospecimens. Aigora assembles such resources from its network of healthcare partner sites, tailored to the specific requirements of each research question.
Aigora now counts six of the world’s top 10 pharmaceutical companies among its customers.
About Aigora
Aigora is a real-world data partner for life sciences and medtech companies. Through its network of healthcare partner sites across Europe and beyond, Aigora discovers, sources, curates and delivers multimodal, regulatory-grade datasets tailored to specific research and development needs.